Skip to main content
ARQT logo
ARQT
(NASDAQ)
Arcutis Biotherapeutics, Inc.
$23.63-- (--)
Loading... - Market loading

Arcutis Biotherapeutics, Inc. (ARQT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Arcutis Biotherapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Strong Buy
Based on 7 unique analysts
(10 total ratings in last 90 days)
Medium Confidence:1 Buy/Sell

Average Price Target

$34.43
45.70% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ARQT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Uy Ear
Mizuho
BuyMaintains
$37.00 $35.00
Seamus Fernandez
Guggenheim
Strong BuyMaintains
$34.00 $35.00
Seamus Fernandez
Guggenheim
BuyReiterates
$34.00 $35.00
Douglas Tsao
HC Wainwright
Strong BuyMaintains
$30.00 $34.00
Tyler Van Buren
TD Cowen
Strong BuyMaintains
$30.00 $35.00
Serge Belanger
Needham
Strong BuyMaintains
$31.00 $36.00
Judah Frommer
Morgan Stanley
BuyMaintains
$35.00
Uy Ear
Mizuho
BuyMaintains
$37.00
Serge Belanger
Needham
Strong BuyMaintains
$30.00 $31.00
Kambiz Yazdi
BTIG
BuyMaintains
$31.00

Frequently Asked Questions

What is the analyst consensus rating for ARQT?

The analyst consensus rating for ARQT is "Strong Buy" based on 7 analyst recommendations.

What is the average price target for ARQT?

The average 12-month price target for ARQT is $34.43, representing an upside of 45.7% from the current price of $23.63.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.